147.38
price down icon1.01%   -1.56
after-market 시간 외 거래: 151.00 3.62 +2.46%
loading
전일 마감가:
$148.94
열려 있는:
$147.38
하루 거래량:
1.31M
Relative Volume:
1.49
시가총액:
$14.62B
수익:
$2.41B
순이익/손실:
$305.80M
주가수익비율:
49.96
EPS:
2.95
순현금흐름:
$492.20M
1주 성능:
+3.35%
1개월 성능:
+3.82%
6개월 성능:
+38.48%
1년 성능:
+26.88%
1일 변동 폭
Value
$146.62
$149.98
1주일 범위
Value
$141.26
$149.98
52주 변동 폭
Value
$84.23
$154.61

뉴로크린 바이오사이언시스 Stock (NBIX) Company Profile

Name
명칭
Neurocrine Biosciences Inc
Name
전화
(858) 617-7600
Name
주소
6027 EDGEWOOD BEND COURT, SAN DIEGO, CA
Name
직원
1,800
Name
트위터
Name
다음 수익 날짜
2024-10-30
Name
최신 SEC 제출 서류
Name
NBIX's Discussions on Twitter

NBIX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
NBIX
Neurocrine Biosciences Inc
147.38 14.77B 2.41B 305.80M 492.20M 2.95
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
145.43 65.38B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.11 44.75B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.10 40.97B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
19.79 22.50B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
415.34 19.04B 3.08B 1.24B 1.07B 25.61

뉴로크린 바이오사이언시스 Stock (NBIX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-10-21 개시 Citigroup Buy
2025-07-21 개시 Truist Buy
2025-07-10 개시 Goldman Buy
2025-04-15 업그레이드 Needham Hold → Buy
2025-04-14 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2025-02-11 개시 Deutsche Bank Hold
2024-10-10 재개 Raymond James Outperform
2024-08-29 업그레이드 Piper Sandler Neutral → Overweight
2024-04-24 업그레이드 Wells Fargo Equal Weight → Overweight
2023-12-13 재개 Citigroup Neutral
2023-12-12 개시 Deutsche Bank Buy
2023-10-24 재개 Cantor Fitzgerald Overweight
2023-08-21 재확인 Mizuho Neutral
2023-07-24 업그레이드 SVB Securities Market Perform → Outperform
2023-07-06 업그레이드 BMO Capital Markets Underperform → Market Perform
2023-05-04 업그레이드 Guggenheim Neutral → Buy
2023-03-30 업그레이드 Canaccord Genuity Hold → Buy
2023-03-03 업그레이드 Evercore ISI In-line → Outperform
2023-02-03 업그레이드 Morgan Stanley Equal-Weight → Overweight
2022-11-14 다운그레이드 Evercore ISI Outperform → In-line
2022-10-11 개시 UBS Buy
2022-09-26 개시 Wells Fargo Equal Weight
2022-06-06 재개 Jefferies Buy
2022-03-03 다운그레이드 Piper Sandler Overweight → Neutral
2022-02-25 업그레이드 Goldman Neutral → Buy
2022-01-18 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2021-11-19 개시 BMO Capital Markets Underperform
2021-11-17 업그레이드 JP Morgan Neutral → Overweight
2021-10-14 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2021-09-23 재개 Needham Hold
2021-08-06 다운그레이드 Canaccord Genuity Buy → Hold
2021-05-18 재개 Goldman Neutral
2021-05-06 업그레이드 Barclays Equal Weight → Overweight
2021-02-02 개시 Raymond James Outperform
2020-09-30 개시 The Benchmark Company Hold
2020-08-04 다운그레이드 JP Morgan Overweight → Neutral
2020-06-29 다운그레이드 Goldman Buy → Neutral
2020-06-09 개시 Wedbush Outperform
2020-03-06 개시 Citigroup Buy
2020-02-27 개시 Barclays Equal Weight
2020-02-24 개시 William Blair Outperform
2020-02-06 개시 Mizuho Neutral
2020-02-05 재확인 H.C. Wainwright Buy
2019-12-13 다운그레이드 Credit Suisse Outperform → Neutral
2019-08-07 개시 RBC Capital Mkts Outperform
2019-07-16 개시 Oppenheimer Outperform
2019-06-05 개시 Guggenheim Neutral
2019-05-21 개시 Credit Suisse Outperform
2019-04-22 업그레이드 JP Morgan Neutral → Overweight
2019-04-12 개시 Evercore ISI Outperform
2019-02-06 재확인 BofA/Merrill Buy
2019-01-23 다운그레이드 JP Morgan Overweight → Neutral
2018-12-13 개시 Goldman Buy
2018-11-21 개시 Canaccord Genuity Buy
모두보기

뉴로크린 바이오사이언시스 주식(NBIX)의 최신 뉴스

pulisher
07:46 AM

What RSI levels show for Neurocrine Biosciences Inc. (NB3) stockJuly 2025 Final Week & Free Weekly Chart Analysis and Trade Guides - newser.com

07:46 AM
pulisher
07:07 AM

Why Neurocrine Biosciences Inc. (NB3) stock could rally stronglyLayoff News & Community Verified Watchlist Alerts - newser.com

07:07 AM
pulisher
05:57 AM

Can Neurocrine Biosciences Inc. stock sustain revenue growthQuarterly Market Summary & AI Enhanced Execution Alerts - newser.com

05:57 AM
pulisher
04:22 AM

Is it time to cut losses on Neurocrine Biosciences Inc.2025 Price Momentum & Weekly Hot Stock Watchlists - newser.com

04:22 AM
pulisher
04:12 AM

Is Neurocrine Biosciences Inc. (NB3) stock a buy during volatile marketsMarket Trend Review & Free Real-Time Volume Trigger Notifications - newser.com

04:12 AM
pulisher
04:11 AM

Is Neurocrine Biosciences Inc. (NB3) stock vulnerable to rate hikesEarnings Overview Summary & Expert Approved Momentum Ideas - newser.com

04:11 AM
pulisher
03:18 AM

Can Neurocrine Biosciences Inc. stock hit analyst price targetsWeekly Gains Report & Daily Risk Controlled Trade Plans - Fundação Cultural do Pará

03:18 AM
pulisher
Oct 27, 2025

How risky is Neurocrine Biosciences Inc. stock nowJuly 2025 Intraday Action & Fast Gain Stock Tips - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Short interest data insights for Neurocrine Biosciences Inc.Portfolio Risk Report & AI Driven Stock Movement Reports - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will Neurocrine Biosciences Inc. (NB3) stock return to pre crash levelsMarket Rally & Risk Controlled Stock Pick Alerts - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

What moving averages say about Neurocrine Biosciences Inc.Insider Selling & Low Risk High Win Rate Stock Picks - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Neurocrine Biosciences (NBIX): Fresh INGREZZA Study Data Renews Focus on Valuation - simplywall.st

Oct 26, 2025
pulisher
Oct 26, 2025

Neurocrine Biosciences Experiences Revision in Its Stock Evaluation Amid Strong Market Performance - Markets Mojo

Oct 26, 2025
pulisher
Oct 25, 2025

Is Neurocrine Biosciences Inc a good long term investmentShort-Term Trading Alerts & You’ll Thank Yourself in 6 Months - earlytimes.in

Oct 25, 2025
pulisher
Oct 25, 2025

Examining Neurocrine Biosciences Valuation After 24% Stock Surge and Pipeline Progress in 2025 - Yahoo Finance

Oct 25, 2025

뉴로크린 바이오사이언시스 (NBIX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
drug_manufacturers_specialty_generic RDY
$14.59
price up icon 0.79%
$10.28
price down icon 1.34%
$22.10
price down icon 0.70%
$415.34
price down icon 1.60%
$47.16
price down icon 1.87%
자본화:     |  볼륨(24시간):